AZD1222 Vaccine for the Prevention of COVID-19

Summary

The purpose of this study is to evaluate safety and immunogenicity of AZD1222 for COVID-19 prevention in the Russian Federation

Timeline

Start

2020-09-02

Primary completion

2020-12-04

Completion

2022-05-11

Outcome

Outcome not reported

Stopped: “The study was put on hold in September 2020 due to a safety concern in another trial but never restarted. In the meantime our clinical development program now includes a similar study with a different design, which we prefer to complete now.”

Drugs

Indications